These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3463778)

  • 21. Effect of tetrahydropyranyladriamycin (THP-ADR) and 4'-epiadriamycin (4'-epi-ADR) on lipid peroxide levels in mice.
    Sadzuka Y; Takino Y
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1329-31. PubMed ID: 1394656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
    Frezard F; Garnier-Suillerot A
    Biochim Biophys Acta; 1990 Nov; 1036(2):121-7. PubMed ID: 2223830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative murine metabolism and disposition of class II anthracycline antibiotics.
    Dodion P; Egorin MJ; Riggs CE; Ferraro TA; Tamburini JM; Bachur NR
    Cancer Chemother Pharmacol; 1985; 15(2):153-60. PubMed ID: 3860304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
    Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB
    Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
    Krishan A; Ganapathi R
    Cancer Res; 1980 Nov; 40(11):3895-900. PubMed ID: 6937236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats].
    Geodakian SV; Firsov AA; Fomina IP
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.
    Israel M; Wilkinson PM; Pegg WJ; Frei E
    Cancer Res; 1978 Feb; 38(2):365-70. PubMed ID: 620407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration.
    Tarasiuk J; Frézard F; Garnier-Suillerot A; Gattegno L
    Biochim Biophys Acta; 1989 Sep; 1013(2):109-17. PubMed ID: 2765536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits (author's transl)].
    Iguchi H; Seryu Y; Kiyosaki T; Hori S; Tone H; Oki T
    Jpn J Antibiot; 1980 Feb; 33(2):169-78. PubMed ID: 6929359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence in sections of cardiac muscle from rats acutely treated with 4'-0-tetrahydropyranil-adriamycin hydrochloride (THP).
    Mazzanti L; Breschi MC; Giovannini L; Bertelli AA
    Drugs Exp Clin Res; 1985; 11(4):281-3. PubMed ID: 3836131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.
    Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of polymer-bound adriamycin.
    Seymour LW; Ulbrich K; Strohalm J; Kopecek J; Duncan R
    Biochem Pharmacol; 1990 Mar; 39(6):1125-31. PubMed ID: 2322298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of epirubicin in cancer patients].
    Ohno T; Shimoyama T; Kimura K; Yamada H
    Gan To Kagaku Ryoho; 1986 May; 13(5):1881-6. PubMed ID: 3458430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat.
    Parker RJ; Priester ER; Sieber SM
    Drug Metab Dispos; 1982; 10(5):499-504. PubMed ID: 6128200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of 4'-deoxy-4'-iodo-doxorubicin in plasma and tissues of tumor-bearing mice compared with doxorubicin.
    Formelli F; Carsana R; Pollini C
    Cancer Res; 1987 Oct; 47(20):5401-6. PubMed ID: 3652044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies of (2''R)-4'-O-tetrahydropyranyl adriamycin (THP).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):237-43. PubMed ID: 3311190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of anticancer drugs and combination effects of anthracyclines on the hypoxic cells of head and neck cancer].
    Fujii M; Ohno Y; Kanzaki J
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):647-52. PubMed ID: 7717716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.